KIM
72
2
DVN
14
-6
COP
57
-2
WMT
56
-4
INTU
58
-3
GD
41
-4
ROP
53
-9
BSX
64
-3
AAP
35
-9
IR
63
-3
CA
22
-3
CRM
60
-7
NEE
54
7
PEP
39
-9
ADP
65
-3
CI
45
-3
LMT
30
-2
HRB
59
2
AAPL
40
-6
SHW
62
-6
KIM
72
2
DVN
14
-6
COP
57
-2
WMT
56
-4
INTU
58
-3
GD
41
-4
ROP
53
-9
BSX
64
-3
AAP
35
-9
IR
63
-3
CA
22
-3
CRM
60
-7
NEE
54
7
PEP
39
-9
ADP
65
-3
CI
45
-3
LMT
30
-2
HRB
59
2
AAPL
40
-6
SHW
62
-6
Financhill
Back

Sarepta Therapeutics Vs. Repligen Industry Stock Comparison

Sell
24

SRPT
Sarepta Therapeutics

Last Price:
104.56
Seasonality Move:
19.2%
Sell
30

RGEN
Repligen

Last Price:
124.90
Seasonality Move:
7.3%
Sell
24
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $104.54. The Score for SRPT is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Repligen (RGEN) is a Sell

Is Repligen a Buy, Sell or Hold?

  • The current Repligen [RGEN] share price is $124.73. The Score for RGEN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $104.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

RGEN Stock Price Chart

What is Repligen's stock price today?

  • The Repligen share price today is $124.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGEN is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.26 Sell
Relative Strength Index (14 RSI): 23.65 Sell
Chaikin Money Flow: -560985 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (116.63 - 130.41) Sell
Bollinger Bands (100): (121.79 - 145.63) Sell

RGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.46 Sell
Relative Strength Index (14 RSI): 36.22 Sell
Chaikin Money Flow: -1285419 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (134.94 - 146.38) Sell
Bollinger Bands (100): (130 - 153.64) Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 116.03 Sell
20-day SMA: 123.12 Sell
50-day SMA: 123.81 Sell
200-day SMA: 130.41 Sell
8-day EMA: 114.12 Sell
20-day EMA: 119.76 Sell
50-day EMA: 124.56 Sell
200-day EMA: 126.9 Sell

RGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 142.02 Sell
20-day SMA: 140.23 Sell
50-day SMA: 141.19 Sell
200-day SMA: 157.58 Sell
8-day EMA: 139.7 Sell
20-day EMA: 140.54 Sell
50-day EMA: 141.71 Sell
200-day EMA: 151.3 Sell

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.55 per share.

Repligen Earnings Growth & RGEN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Repligen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):